(3-nitrobenzoyl)alanine has been researched along with Brain Ischemia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carpenedo, R; Meli, E; Moroni, F; Pellegrini-Giampietro, DE; Peruginelli, F | 1 |
| Carpenedo, R; Cozzi, A; Moroni, F | 1 |
| Carpenedo, R; Cozzi, A; Moroni, F; Pellegrini-Giampietro, DE; Peruginelli, F | 1 |
3 other study(ies) available for (3-nitrobenzoyl)alanine and Brain Ischemia
| Article | Year |
|---|---|
Kynurenine 3-mono-oxygenase inhibitors attenuate post-ischemic neuronal death in organotypic hippocampal slice cultures.
Topics: Alanine; Animals; Brain Ischemia; Cell Death; Cell Hypoxia; Culture Media, Conditioned; Enzyme Inhibitors; Glucose; Hippocampus; In Vitro Techniques; Kynurenic Acid; Kynurenine; Kynurenine 3-Monooxygenase; Mixed Function Oxygenases; Neurons; Neuroprotective Agents; Pyramidal Cells; Quinolinic Acid; Rats; Sulfonamides; Thiazoles | 2002 |
Kynurenine hydroxylase inhibitors reduce ischemic brain damage: studies with (m-nitrobenzoyl)-alanine (mNBA) and 3,4-dimethoxy-[-N-4-(nitrophenyl)thiazol-2yl]-benzenesulfonamide (Ro 61-8048) in models of focal or global brain ischemia.
Topics: Alanine; Animals; Brain Ischemia; Enzyme Inhibitors; Gerbillinae; Kynurenine 3-Monooxygenase; Male; Mixed Function Oxygenases; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Sulfonamides; Thiazoles | 1999 |
Neuroprotective effects of kynurenine-3-hydroxylase inhibitors in models of brain ischemia.
Topics: Alanine; Animals; Brain Ischemia; Cerebral Infarction; Disease Models, Animal; Enzyme Inhibitors; Gerbillinae; Hippocampus; In Vitro Techniques; Ischemic Attack, Transient; Kynurenine 3-Monooxygenase; Mixed Function Oxygenases; Neuroprotective Agents; Pyramidal Cells; Rats; Rats, Wistar; Sulfonamides; Thiazoles | 1999 |